Clin2
NCT07709741Likely a fitNot yet recruiting

Extended-release pill for Parkinson's disease

Healthy Volunteers

Part of Brain & nervous system clinical trials.

This trial tests a new extended-release pill for Parkinson's disease in healthy adults. It helps researchers understand how the drug works in the body before testing it in people with Parkinson's.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
32 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are a healthy adult 18 to 65 years old.
  • You are not taking any daily medications for a medical condition.
  • You are willing and able to follow the study schedule.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07725562Recruiting· Phase 2/Phase 3
Testing a new pill for early-to-mid-stage Parkinson's disease

This trial tests a new tablet (VG081821AC) for people with early-to-mid-stage Parkinson's disease who have not recently used levodopa. The goal is to see if it can improve movement symptoms safely.

Beijing
NCT07781644Not yet recruiting· Phase 1/Phase 2
Testing a new drug for early Parkinson's disease

This study tests an investigational drug to see if it can help people with early Parkinson's disease. It may offer a new treatment option to manage symptoms.

NCT06466525Recruiting· Phase 1
Testing LBT-3627 for safety in healthy adults and people with Parkinson's

This study tests an investigational drug called LBT-3627 to see if it is safe and how the body processes it. It includes healthy volunteers and people with Parkinson's disease, and may help determine if the drug could be a future treatment.

Melbourne, Victoria
NCT06732180Recruiting· Phase 1
Testing a new drug (GT-02287) for Parkinson's disease

This trial tests an investigational drug called GT-02287 in people with early-stage Parkinson's disease (diagnosed within the last 7 years). The goal is to see if it is safe and how the body processes it, with a special focus on people with certain genetic changes (GBA1 mutations) that may be linked to Parkinson's.

Darlinghurst, New South Wales
NCT06976268Recruiting· Phase 2/Phase 3
Testing BHV-8000 for early Parkinson's disease

This study tests a new once-daily pill called BHV-8000 in people who were recently diagnosed with early Parkinson's disease and are not yet on medication. The goal is to see if it can slow the progression of symptoms and improve quality of life.

Birmingham, Alabama
NCT07310264Recruiting· Phase 1
Safety study of a new drug for Parkinson's disease

This trial tests a new drug called VT-5006 to see if it is safe for people with Parkinson's disease. It focuses on those who have stomach or bowel issues, like constipation.

Leiden

Hear when a new Healthy Volunteers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.